1 |
Elsheikh R, Makram AM, Huy NT. Therapeutic Cancer Vaccines and Their Future Implications. Vaccines 2023;11:660. [DOI: 10.3390/vaccines11030660] [Reference Citation Analysis]
|
2 |
Wang F. Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development. Clin Transl Oncol 2023. [PMID: 36781600 DOI: 10.1007/s12094-023-03108-6] [Reference Citation Analysis]
|
3 |
Dutta S, Ganguly A, Chatterjee K, Spada S, Mukherjee S. Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors. Biology (Basel) 2023;12. [PMID: 36829496 DOI: 10.3390/biology12020218] [Reference Citation Analysis]
|
4 |
Li D, Liu Q, Yang M, Xu H, Zhu M, Zhang Y, Xu J, Tian C, Yao J, Wang L, Liang Y. Nanomaterials for mRNA ‐based Therapeutics: Challenges and Opportunities. Bioengineering & Transla Med 2023. [DOI: 10.1002/btm2.10492] [Reference Citation Analysis]
|
5 |
Krause W. mRNA-From COVID-19 Treatment to Cancer Immunotherapy. Biomedicines 2023;11. [PMID: 36830845 DOI: 10.3390/biomedicines11020308] [Reference Citation Analysis]
|
6 |
Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L. Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther 2023;8:9. [PMID: 36604431 DOI: 10.1038/s41392-022-01270-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
7 |
Vishweshwaraiah YL, Dokholyan NV. mRNA vaccines for cancer immunotherapy. Front Immunol 2022;13:1029069. [PMID: 36591226 DOI: 10.3389/fimmu.2022.1029069] [Reference Citation Analysis]
|
8 |
Cohen D, Allouche-Arnon H, Bar-Shir A. MRI reporter genes in the era of gene transfer. Clin Transl Med 2022;12:e1135. [PMID: 36471476 DOI: 10.1002/ctm2.1135] [Reference Citation Analysis]
|
9 |
Santiago-sánchez GS, Hodge JW, Fabian KP. Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation. Front Immunol 2022;13:993624. [DOI: 10.3389/fimmu.2022.993624] [Reference Citation Analysis]
|